Kathleen N. Lohr

How to develop a business case for quality (2007)

Reiter, Kristin L., Kilpatrick, Kerry E., Greene, Sandra B., Lohr, Kathleen N., Leatherman, Sheila

Objective. To describe the steps in developing a business case for quality-enhancing interventions (QEIs) in health care. Analysis. The development of a business case for QEIs in health care involves...

Tobacco Use: Prevention, Cessation, and Control (2006)

Ranney, Leah, Melvin, Cathy, Lux, Linda, McClain, Erin, Morgan, Laura, Lohr, Kathleen N.

Practice Center (RTI-UNC EPC) systematically reviewed the evidence on (a) the effectiveness of community- and population-based interventions to prevent tobacco use and to increase consumer demand for...

How to develop a business case for quality (2006)

Reiter, Kristin L., Kilpatrick, Kerry E., Greene, Sandra B., Lohr, Kathleen N., Leatherman, Sheila

Objective. To describe the steps in developing a business case for quality-enhancing interventions (QEIs) in health care. Analysis. The development of a business case for QEIs in health care involves...

How to develop a business case for quality (2006)

Reiter, Kristin L., Kilpatrick, Kerry E., Greene, Sandra B., Lohr, Kathleen N., Leatherman, Sheila

Objective. To describe the steps in developing a business case for quality-enhancing interventions (QEIs) in health care. Analysis. The development of a business case for QEIs in health care involves...

The insufficiency of evidence to establish the business case for quality (2005)

Kilpatrick, Kerry E., Lohr, Kathleen N., Leatherman, Sheila, Pink, George, Buckel, Jean M., Legarde, Caroline, ...

Purpose. To determine whether a positive financial return on investment for quality-enhancing interventions is more likely for particular health conditions, in specific organizational settings, or...

The insufficiency of evidence to establish the business case for quality (2005)

Kilpatrick, Kerry E., Lohr, Kathleen N., Leatherman, Sheila, Pink, George, Buckel, Jean M., Legarde, Caroline, ...

Purpose. To determine whether a positive financial return on investment for quality-enhancing interventions is more likely for particular health conditions, in specific organizational settings, or...

The insufficiency of evidence to establish the business case for quality (2005)

Kilpatrick, Kerry E., Lohr, Kathleen N., Leatherman, Sheila, Pink, George, Buckel, Jean M., Legarde, Caroline, ...

Purpose. To determine whether a positive financial return on investment for quality-enhancing interventions is more likely for particular health conditions, in specific organizational settings, or...

Rating the strength of scientific evidence: relevance for quality improvement programs (2004)

Lohr, Kathleen N.

Objectives. To summarize an extensive review of systems for grading the quality of research articles and rating the strength of bodies of evidence, and to highlight for health professionals and...

Assessing the need to update prevention guidelines: a comparison of two methods (2004)

Gartlehner, Gerald, West, Suzanne L., Lohr, Kathleen N., Kahwati, Leila, Johnson, Jana G., Harris, Russell P., ...

Background. An important concern for developers of clinical practice guidelines is how best to determine when guidelines require updating to ensure they remain current and evidence based. Because of...

Proof and Policy from Medical Research Evidence (2001)

Mulrow, Cynthia D., Lohr, Kathleen N.

When judging the benefits and harms of health care and predicting patient prognosis, clinicians, researchers, and others must consider many types of evidence. Medical research evidence is part of the...

Guidelines for Clinical Practice: Applications for Primary Care (1994)

LOHR, KATHLEEN N.

Practice guidelines can make considerable contributions to several areas of health care delivery. Perhaps their greatest promise lies in the area of assessing and improving the quality of health care...

The effect of cost sharing on the use of antibiotics in ambulatory care: Results from a population-based randomized controlled trial, (1987)

Foxman, Betsy, Valdez, R. Burciaga, Lohr, Kathleen N., Goldberg, George A., Newhouse, Joseph P., Brook, Robert H.

Little is known about how generosity of insurance and population characteristics affect quantity or appropriateness of antibiotic use. Using insurance claims for antibiotics from 5765 non-elderly...

Chronic bronchitis: Prevalence, smoking habits, impact, and antismoking advice (1986)

Foxman, Betsy, Sloss, Elizabeth M., Lohr, Kathleen N., Brook, Robert H.

Although the prevalence of chronic bronchitis has been measured in several populations, its impact on quality of life has not been assessed. We report the prevalence and impact of chronic bronchitis...

Chronic Disease in a General Adult Population: Findings From the Rand Health Insurance Experiment

Lohr, Kathleen N., Kamberg, Caren J., Goldberg, George A., Brook, Robert H., Keeler, Emmett B., Calabro, Thomas A.

Using questionnaire and physical screening examination data for a general population of 4,962 adults aged 18 to 61 years enrolled in the Rand Health Insurance Experiment, we calculated the prevalence...

Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes

Gartlehner, Gerald, Hansen, Richard A., Carson, Shannon S., Lohr, Kathleen N.

PURPOSE We wanted to review systematically the efficacy, effectiveness, and safety of inhaled corticosteroids with respect to health outcomes in patients with chronic obstructive pulmonary disease...

Chronic Disease in a General Adult Population: Findings From the Rand Health Insurance Experiment

Lohr, Kathleen N., Kamberg, Caren J., Goldberg, George A., Brook, Robert H., Keeler, Emmett B., Calabro, Thomas A.

Using questionnaire and physical screening examination data for a general population of 4,962 adults aged 18 to 61 years enrolled in the Rand Health Insurance Experiment, we calculated the prevalence...

Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes

Gartlehner, Gerald, Hansen, Richard A., Carson, Shannon S., Lohr, Kathleen N.

PURPOSE We wanted to review systematically the efficacy, effectiveness, and safety of inhaled corticosteroids with respect to health outcomes in patients with chronic obstructive pulmonary disease...

The Potential Impact of Measuring Healthcare Quality on Pharmaceutical-Related Costs and Outcomes

William L. Roper, R. Tamara Hodlewsky, Hugh Tilson, Kathleen N. Lohr, William H. Campbell

Quality measurement has achieved a powerful momentum across the spectrum of healthcare, driven primarily by the search for strategies to contain rapidly rising healthcare costs without sacrificing...